Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Inclusion complex of thymol and hydroxypropyl-β-cyclodextrin (HP-β-CD) in polymeric hydrogel for topical application: Physicochemical characterization, molecular …
The current investigation aimed to prepare and characterize the inclusion complex of thymol
with hydroxypropyl-β-cyclodextrin (HP-β-CD) to uniformly incorporate in hydrogel system for …
with hydroxypropyl-β-cyclodextrin (HP-β-CD) to uniformly incorporate in hydrogel system for …
A Comprehensive Study on Provesicular Drug Delivery System: Proniosomal Gel.
S Govindarajan… - Indian Journal of …, 2022 - search.ebscohost.com
Vesicular approaches are novel techniques for transporting the drug that reinforces the
availability of drugs and gives an action for a prolonged time. Besides, it has definite …
availability of drugs and gives an action for a prolonged time. Besides, it has definite …
Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid
In the present study, pluronic lecithin based organogels (PLO gels) were formulated as
topical carrier for controlled delivery of mefenamic acid. Ten organogel formulations were …
topical carrier for controlled delivery of mefenamic acid. Ten organogel formulations were …
[PDF][PDF] Effect of carbopol 934 and 940 on fluconazole release from topical gel formulation: a factorial approach
The aim of present research is to investigate the effect of various carbopols (934 and 940)
on drug release from fluconazole gel formulation developed for topical application …
on drug release from fluconazole gel formulation developed for topical application …
[PDF][PDF] Formulation and evaluation of lisinopril dihydrate transdermal proniosomal gels
M Sabareesh, PR Khan, B Sudheer - Journal of applied …, 2011 - japsonline.com
In the present study transdermal Lisinopril proniosomal gels was formulated by using
Lecithin, Cholesterol as encapsulating agents, Surfactant, Span and permeation enhancers …
Lecithin, Cholesterol as encapsulating agents, Surfactant, Span and permeation enhancers …
[PDF][PDF] A novel vesicular approach for transdermal administration of enalapril maleate loaded nanoproniosomal gel: Formulation, ex vivo evaluation and in vivo …
M Sabareesh, JP Yanadaiah… - International Journal of …, 2020 - academia.edu
Objective: The objective of the study was to formulate and evaluate the nanoproniosomal gel
of Enalapril maleate (EM) for the treatment of hypertension through the transdermal …
of Enalapril maleate (EM) for the treatment of hypertension through the transdermal …
Formulation development, Ex vivo evaluation and In vivo antihypertensive study of losartan potassium loaded nanoproniosomal gel: A novel vesicular approach for …
M Sabareesh, JP Yanadaiah… - Research Journal of …, 2021 - indianjournals.com
The transdermal nanoproniosomal gel of Losartan potassium was prepared to treat
hypertension that is efficient to deliver the encapsulated drug over extended periods and to …
hypertension that is efficient to deliver the encapsulated drug over extended periods and to …
[PDF][PDF] Carbopol and sodium carboxymethylcellulose based methylsulfonylmethane gels for treatment of osteoarthritis: in-vitro and in-vivo evaluation
V Ghorpade, K Mali, R Dias, P Karande - Ind J Pharm Edu Res, 2012 - ijper.org
The objective of present study was to prepare transdermal gels of methylsulfonylmethane
(MSM) alone or in combination with aloe vera and sesame oil using polymers like carbopol …
(MSM) alone or in combination with aloe vera and sesame oil using polymers like carbopol …
Novel nanoproniosomal vesicular carriers for the effective and efficient drug delivery: fundamentals, recent advancements and applications
M Sabareesh, JP Yanadaiah… - Research Journal of …, 2021 - indianjournals.com
Nanotechnology is an emerging technology that has brought the upheaval reforms in the
domain of pharmaceutical sciences including the development of nanovesicular drug …
domain of pharmaceutical sciences including the development of nanovesicular drug …
Proniosomes Nanoparticle for the Treatment of Peripheral Arterial Disease
PA Panchal, S Patel, A Patel… - Pharmaceutical …, 2024 - benthamdirect.com
Background: The common symptom of systemic atherosclerosis is peripheral arterial
disease (PAD), which occurs when the artery lumen in the lower extremities gradually …
disease (PAD), which occurs when the artery lumen in the lower extremities gradually …